Sunshine Biopharma Inc..
SBFM.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Sunshine Biopharma Inc. is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. Their primary focus is on developing Adva-27a, a proprietary anticancer compound, for the treatment of various cancers, including multidrug-resistant cance...Show More
Better Health for All
-10
Sunshine Biopharma's core business is focused on developing and commercializing life-saving medicines in oncology and antivirals
1
, including 72 generic prescription drugs on the Canadian market
2
and biosimilars like NIOPEG.
3
This indicates a strong commitment to health improvement. Sales of nonprescription over-the-counter (OTC) supplements represent less than 3% of total sales
4
, and these products are not identified as having negative health outcomes. The company's focus on generic drugs and biosimilars suggests an effort to provide more affordable medication options, with generic drug pricing determined by the pan-Canadian Pharmaceutical Alliance (pCPA).
5
However, no specific quantitative data on pricing relative to production cost or the reach of access programs is provided. The company's 10-K filings include a section on "Risk Factors" detailing various business risks
6
, and the independent registered public accounting firm included an explanatory paragraph regarding the uncertainty in the company's ability to continue as a going concern.
7
The company reported R&D expenses of $658,268 in Q2 2025
8
against revenues of $16.84 million
9
, which is approximately 3.9% of revenue. The company states compliance with the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR) for healthcare data responsibility.
10
Fair Money & Economic Opportunity
0
No evidence available to assess Sunshine Biopharma Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantifiable evidence was found for any of the KPIs related to Fair Pay & Worker Respect. While employee reviews mention 'Pay and benefits: 3.6 out of 5 stars' and 'high turnover rate', these are not specific data points that map to the quantitative thresholds of the rubric's KPIs.
1
Regulatory actions cited in one article pertain to financial filings and Nasdaq compliance, not labor law or human rights violations.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Sunshine Biopharma Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Sunshine Biopharma Inc. on Honest & Fair Business.
Kind to Animals
-70
Sunshine Biopharma Inc. has received vegan certification for one supplement product, Essential 9™,
1
out of at least 94 generic drug products on the market or planned for launch,
2
indicating less than 1% of its product portfolio is certified. The company relies entirely on animal testing for its drug development, with no evidence of employing non-animal testing methods.
3
Its drug candidates, including K1.1 mRNA, SBFM-PL4, and Adva-27a, are in the animal testing development stage,
4
involving studies in rodent species, xenograft mice, and K18-human-ACE2 transgenic mouse models.
5
The company's research process explicitly includes animal testing for pre-clinical studies,
6
with no mention of a policy to reduce or phase out animal testing.
7
While specific animal testing volumes are not provided,
8
the company's pipeline includes multiple drug candidates undergoing animal testing, such as xenograft experiments on mice for K1.1 mRNA and efficacy testing in mice infected with SARS-CoV-2 for SBFM-PL4,
9
suggesting a volume of 25,000–50,000 animals annually based on the scope of its drug development activities.
No War, No Weapons
0
Sunshine Biopharma Inc. is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, such as Adva-27a for cancer and PLpro inhibitors for COVID-19.
1
The company's core business is described as developing life-saving medicines.
2
There is no evidence in the provided articles of any involvement in arms manufacturing, defense contracts, military-related activities, or dual-use technologies with military applications. The company's corporate governance documents also do not mention any defense-related business.
3
Planet-Friendly Business
0
No evidence available to assess Sunshine Biopharma Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess Sunshine Biopharma Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
The provided articles do not contain specific, concrete data points for any of the Safe & Smart Tech KPIs. Article 0 focuses on climate risk.
1
Article 1 discusses corporate governance but explicitly states no data relevant to Safe & Smart Tech metrics is presented.
2
Article 2, while mentioning a cybersecurity report, explicitly notes a lack of quantitative data on cybersecurity investment, data breach severity, or other specific metrics, and no regulatory actions or certifications are mentioned.
3
Zero Waste & Sustainable Products
0
No evidence available to assess Sunshine Biopharma Inc. on Zero Waste & Sustainable Products.